Quick Answer
Avocado-Blood-Lipids-Meta-Analysis has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: Background Avocado consumption has been associated with improvements in diet quality and cardiometabolic risk factors, but effects on serum metabolite profiles remain underexplored.
Key Takeaways
- 01Background Avocado consumption has been associated with improvements in diet quality and cardiometabolic risk factors, but effects on serum metabolite profiles remain underexplored. [Matthan NR (2026)]
- 02Pre-post intervention changes in metabolites, cardiometabolic risk factors (blood pressure, lipid profile, glucose, insulin, high-sensitivity C-reactive protein), visceral adipose tissue volume, and hepatic fat fraction were evaluated using Wilcoxon tests. [Matthan NR (2026)]
- 03Conclusions Avocado intake was associated with subtle shifts in serum metabolites related to lipid, carbohydrate, and amino acid metabolism, with weak effects on visceral adipose tissue volume, plasma triglycerides, and total cholesterol concentrations. [Matthan NR (2026)]
- 04Methods Secondary analysis was conducted using untargeted metabolomics to assess fasting serum metabolite profiles at baseline (preintervention) and 6 months (postintervention) in a subset of participants with abdominal obesity from the HAT (Habitual Diet and Avocado Trial), who were randomized to the avocado group (n = 120; 70% women; 49 ± 13 years of age; body mass index 33.1 ± 5.7 kg/m 2 ). [Matthan NR (2026)]
The current Migaku evidence database contains 2 reusable source documents for Avocado-Blood-Lipids-Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation.
- Background Avocado consumption has been associated with improvements in diet quality and cardiometabolic risk factors, but effects on serum metabolite profiles remain underexplored. [Matthan NR (2026); evidence level 4]
- Pre-post intervention changes in metabolites, cardiometabolic risk factors (blood pressure, lipid profile, glucose, insulin, high-sensitivity C-reactive protein), visceral adipose tissue volume, and hepatic fat fraction were evaluated using Wilcoxon tests. [Matthan NR (2026); evidence level 4]
- Conclusions Avocado intake was associated with subtle shifts in serum metabolites related to lipid, carbohydrate, and amino acid metabolism, with weak effects on visceral adipose tissue volume, plasma triglycerides, and total cholesterol concentrations. [Matthan NR (2026); evidence level 4]
- Methods Secondary analysis was conducted using untargeted metabolomics to assess fasting serum metabolite profiles at baseline (preintervention) and 6 months (postintervention) in a subset of participants with abdominal obesity from the HAT (Habitual Diet and Avocado Trial), who were randomized to the avocado group (n = 120; 70% women; 49 ± 13 years of age; body mass index 33.1 ± 5.7 kg/m 2 ). [Matthan NR (2026); evidence level 4]
- People with prediabetes are at high risk for T2D and more likely to develop and have complications of endothelial dysfunction, leading to macrovascular and microvascular diseases.The economic burden of diabetes and its complications was estimated at $412.9 billion in 2022.Currently, the most cost‐effective treatment is prevention and is a major public health priority. [Preiss Chelsea (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources